Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

SELL
$343.0 - $410.68 $1,029 - $1,232
-3 Reduced 42.86%
4 $1,000
Q3 2023

Oct 11, 2023

BUY
$338.18 - $362.46 $2,367 - $2,537
7 New
7 $2,000
Q2 2020

Jul 13, 2020

SELL
$225.48 - $295.8 $676 - $887
-3 Closed
0 $0
Q1 2020

Apr 10, 2020

BUY
$199.77 - $247.81 $599 - $743
3 New
3 $1,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Perkins Coie Trust CO Portfolio

Follow Perkins Coie Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.